Eu Approves Novartis- Glaxosmithkline Deal

The drug giants won European Union regulatory approval for a complicated series of deals worth more than $20 billion that will focus Novartis’ scope and turn Glaxo into a vaccines-and-consumer-drug powerhouse.

Topics:  european union   novartis    glaxo   deal   
BING NEWS:
  • GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
    GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster ...
    04/25/2024 - 4:22 am | View Link
  • FDA Approves Novartis' Lutathera for Children With Neuroendocrine Cancers
    The approval makes the radioligand therapy available to patients 12 and older with SSTR-positive gastroenteropancreatic neuroendocrine tumors.
    04/23/2024 - 8:13 am | View Link
  • EU approves Pfizer antibiotic for superbug infections
    Pfizer’s Emblaveo has been approved in the EU with a first-in-class indication in multidrug-resistant (MDR) infections. The drug – a combination of beta-lactam antibiotic aztreonam with beta ...
    04/22/2024 - 12:59 pm | View Link
  • EU approves major overhaul of migration rules
    After years of negotiations, the European Parliament has approved a major reform tightening the EU's migration and asylum rules. The EU Asylum and Migration Pact has been in the works since 2015 ...
    04/10/2024 - 1:03 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News